Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by ketchenergyon Jun 28, 2019 10:45pm
96 Views
Post# 29875530

RE:RE:First quarter financials

RE:RE:First quarter financialsI agree the MD&A is informative! having trever dixon running this really helps, it shows right away via clear communication and focus on completing phase 3! focus on production! No more wishy washy . Ok, 18 millon in working capital as of jan 31 2019. Expect to lose less sort term as costs are fixed, construction etc etc. Short term liabilities 8.8 million next 12 months. MD&A was excellent giving fall as completion of phase 3, thus around 18,000 kg yearly production not bad at all! should have occurred Jan 2019 as I recall and based my investment. So lets expect nice revenue growth here, and revenue has grown ( albiet lower then i thought ). Other things interesting targeting small and mid companies? maybe revisit gtec? Also commenting on gtec opening retail ( gtec has not done so yet and I must look a little deeper for that information from gtec)  Any additional distrubution channels are positive. continue to mention the EU cert for germany with agreement still in place. Also almost 500,000 grams in inventory ( about 2.5 million rev)  bottom line ? better now with Dixon but tight cash!! better news releases fall for phase 3, and next Q better with CEO in charge. Good buy considering the growth in production coming soon. I think a merger with gtec rather then takeover is coming? gtec just did small finacing so cash.
<< Previous
Bullboard Posts
Next >>